Regeneron Pharmaceuticals Inc - Company & Market Research Reports

Home /
Companies /
Regeneron Pharmaceuticals Inc

Regeneron is a biotechnology company with its headquarters in New York City. Their product portfolio includes Praluent, Eylea and Arcalyst. Regeneron is a key player in research and development including drug discovery, human antibody technologies and genomics. Regeneron scientists focus on discovering new drug targets and developing effective product candidates through the proprietary VelociSuite platform of genetic technologies. In 2015 Regeneron announced a new collaboration with Sanofi to develop immuno-oncology treatments with a plan to begin clinical trials in 2016.

REFINE BY

KEYWORD

CATEGORIES

Drug Discovery 84
Oncology Drugs 79
Optical Disorders Drugs 78
Optical 75
Immune Disorders Drugs 67
Cardiovascular Drugs 46
Biopharmaceuticals 40
Dermatological Drugs 38
Musculoskeletal Disorders Drugs 38
Genomics 30
Biotechnology 28
Clinical Trials 28
Endocrine and Metabolic Disorders Drugs 27
Pharmaceuticals 22
Skin Cancer Drugs 21
Infectious Diseases Drugs 19
Allergy and Immunology 17
Central Nervous System Drugs 17
Respiratory Drugs 17
Gastrointestinal Drugs 14
Allergy Drugs 14
Infusions and Injectables 13
Drugs by Therapeutic Area 11
Lung Cancer Drugs 11
Hematological Drugs 11
Leukemia Drugs 9
Dermatology 8
Oncology 8
Asthma Drugs 8
Pharmaceutical Manufacturing 8
Analgesics 7
Diagnostics 7
Needles and Syringes 7
Biosimilars and Biosuperiors 6
Therapeutic Area 5
Prostate Cancer Drugs 5
Lymphoma Drugs 5
Enzymes 5
Company Reports 4
Ovarian Cancer Drugs 4
Cardiovascular Devices 4
Transdermal and Transmucosal Drug Delivery 4
Vaccines 4
Liver and Kidney Disorders Drugs 4
Gastroenterology 4
Pharmaceutical Intermediates 3
Pulmonary Medicine 3
Colon Cancer Drugs 3
Proteomics 3
Drug Delivery 3
Laboratory Equipment 3
Sexual and Reproductive Health Drugs 3
Immunosuppressive Drugs 3
Liver Cancer Drugs 2
Diabetes Drugs 2
Healthcare Services 2
Cervical Cancer Drugs 2
Brain Cancer Drugs 2
Cough and Cold Drugs 2
Medical Devices 2
Mental Disorders Drugs 2
Pancreatic Cancer Drugs 2
Kidney Cancer Drugs 2
Anti-Obesity Drugs 2
Pediatrics 2
Neurology 1
Generic Drugs 1
Pharmacoeconomics 1
Fertility Services 1
Bladder Cancer Drugs 1
In Vitro Diagnostics 1
Infectious Disease Testing 1
Laboratory Testing 1
Animal Healthcare/Veterinary 1
Diabetes Devices 1
Stem Cells 1
Blood Banking 1
Biomarkers 1
Hematology 1
Surgical Devices 1
Over the Counter (OTC) Drugs 1
Endoscopy 1
Thyroid Cancer Drugs 1
Uterine Cancer Drugs 1
Nanomedicine 1
Cardiology 1
Endocrinology 1
Alzheimer's Disease Drugs 1
Psoriasis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



276 reviews

676 Results (Page 17 of 34)
- Relevance
  Sort by

Hypercholesterolemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
October 2022
210 Pages
Global

From

€1958EUR$2,000USD£1,629GBP

Erdheim Chester Disease Global Market Report 2024

 Report
February 2024
175 Pages
Global

From

€4896EUR$5,000USD£4,072GBP

Hypercholesterolemia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

 Report
March 2022
1284 Pages
Global

From

€2448EUR$2,500USD£2,036GBP

Stroke Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
August 2022
580 Pages
Global

From

€2448EUR$2,500USD£2,036GBP

Atherosclerosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
August 2022
243 Pages
Global

From

€2448EUR$2,500USD£2,036GBP

NEED HELP FINDING THE RIGHT PRODUCT? Craig will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Light Activated Therapies Market: Focus on Photodynamic Therapies, Photoimmunotherapies and Photothermal Therapies - Distribution by Target Indications, Key Players and Geographies: Industry Trends and Global Forecasts, 2021-2030

 Report
September 2021
140 Pages
Global

From

€4699EUR$4,799USD£3,908GBP

Nasal Drug Delivery Technology Global Market Report 2024

 Report
January 2024
200 Pages
Global

From

€4896EUR$5,000USD£4,072GBP

Aspergillosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
September 2022
104 Pages
Global

From

€1958EUR$2,000USD£1,629GBP

Viral Gastroenteritis Global Market Report 2024

 Report
February 2024
175 Pages
Global

From

€4896EUR$5,000USD£4,072GBP

Allogeneic Stem Cell Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 to 2031

 Report
November 2023
110 Pages
Global

From

€4406EUR$4,500USD£3,665GBP

Biologic & Biosimilar RA Drugs Global Market Report 2024

 Report
January 2024
200 Pages
Global

From

€4896EUR$5,000USD£4,072GBP

Peanut Allergy Treatment Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Drug Class (Antihistamines, Epinephrine, Immunotherapies, Others), By Route of Administration, By Distribution Channel, By Region and Competition

 Report
August 2023
117 Pages
Global

From

€4406EUR$4,500USD£3,665GBP

Metastatic Prostate Cancer - Pipeline Insight, 2024

 Clinical Trials
June 2024
240 Pages
Global

From

€2056EUR$2,100USD£1,710GBP

€2937EUR$3,000USD£2,443GBP

Dyslipidemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
April 2022
330 Pages
Global

From

€2448EUR$2,500USD£2,036GBP

Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment - Global Strategic Business Report

 Report
November 2024
93 Pages
Global

From

€5483EUR$5,600USD£4,560GBP

Small Cell Lung Cancer Therapeutics Global Market Report 2024

 Report
January 2024
175 Pages
Global

From

€4896EUR$5,000USD£4,072GBP

Lung Cancer Drugs Global Market Report 2024

 Report
November 2023
175 Pages
Global

From

€4896EUR$5,000USD£4,072GBP

Transthyretin (ATTR or Prealbumin or TBPA or TTR) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
September 2022
85 Pages
Global

From

€3427EUR$3,500USD£2,850GBP

Global Therapeutic Vaccines Market Distribution by Type of Vaccine, Method of Vaccine Composition, Type of Therapy, Target Disease Indication, Route of Administration and Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2035

 Report
May 2022
365 Pages
Global

From

€4699EUR$4,799USD£3,908GBP

Allergic Rhinitis - Pipeline Insight, 2024

 Clinical Trials
April 2024
60 Pages
Global

From

€1371EUR$1,400USD£1,140GBP

€1958EUR$2,000USD£1,629GBP

676 Results (Page 17 of 34)
- 1
- 15
- 16
- 17
- 18
- 19

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.